New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.

New Warning Labels for Opioids

FDA applies black-box warning to mixing opioids and benzodiazepines in an effort to prevent overdoses.

Opioid Label / Photo: Associated Press
Opioid Label / Photo: Associated Press

A recent CNN article discussed the FDA’s recent action to warn consumers of the dangers of mixing opioids and benzodiazepines. As the result of a citizen petition, the FDA has enforced black-box warnings, which is the highest-level warning. In the period from 2004 to 2011, the number of overdose deaths from mixing these two drugs has tripled, and the number of patients prescribed both a narcotic and a benzodiazepine has gone up 41%.

Now, when a patient gets their prescription filled, the bottle should have a notification that indicates a black-box warning for the drug, but the consumer will need to visit the manufacturer’s website for details. "It is nothing short of a public health crisis when you see a substantial increase of avoidable overdose and death related to two widely used drug classes being taken together,” said FDA Commissioner, Robert Califf.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts